|
Discussion - Part 2 (Investigating Adverse Events)
This section will review best practices for
investigating suspected transfusion complications, including the
differential diagnosis of post-transfusion fever, a key part of Case
O-6. Also see investigation protocols discussed in
Case O-5. The discussion is not
meant to be definitive or all inclusive.
Patient and Donor Identity
When any
transfusion adverse event or complication is suspected, checking that
the right blood went to right patient should
be one of the first steps after stopping the transfusion:
- Check the identity and compatibility of patient and donor
- Confirm that the patient's name and hospital number on the
blood bag label match the information on the patient's ID
wristband.
- Verify that the blood component donor number is correct and
intended for the patient and that blood groups (and crossmatch,
if done) are compatible between patient and donor
Immediate
Investigation Protocols
Recognizing the signs and symptoms of a
transfusion reaction and acting promptly and appropriately are critical
to reducing serious consequences to transfusion recipients.
When a transfusion reaction or any transfusion
adverse event or complication is suspected, best practice includes these
process steps:
Immediately investigate the suspected transfusion reaction.
- Stop the
transfusion immediately
- Maintain intravenous access
with 0.9% saline.
- Check the identity and compatibility of patient and donor
("right blood to right patient" as above)
- Seek medical help
- Notify the transfusion service that a suspected
transfusion reaction has occurred and briefly describe the adverse
event
- Investigate according to
hospital policies and procedures related to the identification
and management of transfusion reactions.
Further investigation
How to investigate reactions further
depends on the type of complication. Because
some symptoms may be common to several types of complications, all possibilities must be considered initially until a
differential diagnosis leads to the final diagnosis.
DIFFERENTIAL DIAGNOSIS
The differential diagnosis of patients who experience fever during or
shortly thereafter transfusion includes
- Febrile non-hemolytic transfusion reactions
- Immediate hemolytic transfusion reactions
- TRALI
- Bacterially contaminated blood products
FEBRILE NON-HEMOLYTIC
transfusion reactions (FNHTR)
FNHTR are one of the most common transfusion
complications and have been defined as a rise of 1°C (with or without
concurrent chills) for which no other cause can be identified. Signs and
symptoms usually appear towards the end of transfusion or
sometimes 1–2
hours later.
Because fever may occur in hemolytic and
bacteriogenic transfusion reactions, an investigation is required to
eliminate these serious complications. The
transfusion service (TS)
should have policies for how to investigate
suspected FNHTR and whether or not transfusions can be restarted. Due to
the risk of more serious reactions, extreme caution should be used if
restarting transfusion, which should be done only with a physician's
orders and with the patient carefully observed throughout.
The most likely cause of FNHTR due to RBC transfusion is patient
antibodies directed against leukocytes in the red cell unit, whereas
FNHTR due to platelets are thought to be caused by cytokines that
accumulate in the component during storage. Prestorage leukoreduction
has reduced the frequency of FNHTR but has not entirely eliminated them.
FNHTR - more....
IMMEDIATE HEMOLYTIC
transfusion reactions (IHTR)
IHTR are potentially life-threatening reactions
typically caused by transfusion of ABO-incompatible RBC following
misidentification of the blood recipient.
Signs and symptoms usually appear within minutes
of the start of transfusion but can occur anytime during transfusion.
IHTR are characterized by fever, chills, anxiety, burning along site of
transfusion, hypotension, back pain, and many more signs and symptoms.
Life-threatening complications include hypovolemic shock, disseminated
intravascular coagulation, and renal failure.
IHTR - more....
TRALI
Transfusion-related acute lung injury (TRALI)
has emerged as a leading cause of transfusion-related morbidity
and mortality. It is characterized by acute
respiratory distress following transfusion with plasma-containing blood
products. TRALI is believed to be caused by passive transfusion of donor
leukocyte antibodies triggering complement activation and neutrophil
sequestration and activation in pulmonary capillaries
leading to lung injury. However, in up to one-third of cases no donor
antibodies are implicated.
Symptoms
usually begin within 1–2
hours of transfusion and typically are present by 4–6
hours. Clinical findings include the rapid onset of dyspnea, tachypnea,
cyanosis, pulmonary rales, hypotension (mild to moderate), fever (1–2°C)
and chills, tachycardia, severe hypoxemia, and acute non-cardiogenic
pulmonary edema.
TRALI - more...
BACTERIAL SEPSIS
includes symptoms similar to immediate hemolytic transfusion reactions
and TRALI. Milder reactions may exhibit symptoms identical to
febrile non-hemolytic transfusion reactions. Severe reactions manifest
as fever, hypotension, and vascular collapse, which may include
respiratory distress.
Bacteria in blood components may be due to a wide
variety of causes, including
- contamination during collection (inadequate
aseptic technique in swabbing donor skin; needle coring of donor
skin)
- blood donor infection (transient,
asymptomatic bacteremia or chronic low grade infection)
- improper refrigeration during storage or
transportation
- contamination during pooling of products
- defective blood bags
- transfusing over too long a time
The incidence of transfusion-associated bacteremia
is unknown. Because platelets are stored at RT, they present a greater
risk than RBCs. In the USA bacterial contamination was the second most
common cause of death from transfusion (after clerical errors). In 2004
the AABB Standard 5.1.5.1 mandated
platelet bacterial contamination detection testing.
Bacteria - more...
For an in-depth discussion of bacterial
contamination see Hillyer et al.
For appropriate investigation of all types of transfusion complications, see
Standards and
Regulations
Standards and regulations exist for investigating
suspected transfusion complications. Here are a few sample Canadian
standards showing selected clauses only (not the entire standard).
CSTM
Standards (Z902-04 references as
superscripts)
N2.0 DETECTION,
EVALUATION AND REPORTING
N2.1 A list of common signs and symptoms of suspected adverse
reactions shall be included in both the nursing and TS manuals.
17.2.1
N2.2 All serious adverse reactions shall be immediately
reported to the TS. [see Case O-5: Reporting adverse events]
N2.3 The TS shall investigate all
reports of significant adverse reactions. The aim of the
investigation shall be to determine the probable cause and shall
include appropriate laboratory tests. 17.2.2
N2.6 The original report of an adverse
reaction investigation, including recommendations for management of
future transfusions, shall be placed in the recipient’s permanent
medical record. The TS shall retain a copy,
and the information shall be accessed if the recipient requires
further transfusion. 17.2.3/17.2.4
N4.0 SUSPECTED BACTERIAL SEPSIS
N4.1 All cases of suspected
transfusion-transmitted bacterial sepsis shall be investigated
immediately. The transfusion shall be stopped, and the implicated
blood and blood product returned to the TS. Care should be taken to
avoid further contamination of the product. 17.4.1
N4.2 Investigation of the implicated blood and blood products
shall include preparation of a gram stain and cultures of the
product contents, not segments. Cultures should be performed on
appropriate media with
incubation at both 25oC and 35oC. 17.4.2
N4.3 Investigation should include recipient blood cultures.17.4.3
N4.4 Any bacteria isolated from the blood and blood product
or recipient blood cultures should be retained for further typing if
required. 17.4.4
N4.5 If bacterial contamination is confirmed, the blood
supplier shall be notified for appropriate follow-up. 17.4.5
Clauses also exist for
how to investigate and report
- SUSPECTED HEMOLYTIC TRANSFUSION REACTIONS
(N3.0)
- OTHER SUSPECTED TRANSFUSION-TRANSMITTED
DISEASES (N5.0)
- OTHER ADVERSE
REACTIONS (N6.0)
This Case (Investigating
Adverse Reactions)
Upon discovering the apparent reaction
(patient had started shaking), the nurse's immediate actions followed the procedures detailed
in the facility's nursing manual:
- stopped the
transfusion
- kept the IV open
- examined the blood bags and
accompanying records to ensure that the plasma was the correct ABO
group and was intended for the patient (right blood went to right
patient )
- sought medical help
- called the TS to report the reaction
The
TS
performed a transfusion reaction
investigation according to its policy and procedure manual:
See
Investigation of transfusion reactions (TraQ
Technical
Resource Manual)
- Confirmation of patient and donor identity and a
serologic investigation eliminated an immune hemolytic transfusion reaction as the cause.
- Because a bacteriogenic reaction was
suspected due to fever subsequent to a prolonged transfusion time (8
hrs.+), the returned units were examined
for any abnormal appearance (e.g., clots, brownish,
opaque, muddy, or purple discoloration).
The microbiology laboratory performed gram
stains and cultures of both PRBC contents, as well as recipient blood cultures. All were negative.
- The patient's other signs and symptoms (e.g.,
increase in blood pressure to
150/99) did not fit
TRALI.
SUMMARY:
In the absence of other credible causes, staff
concluded that a febrile non-hemolytic reaction had likely occurred
after the second PRBC and had triggered subsequent events (increased
intracranial pressure, convulsions).
Learning
Points
- Recognizing the signs and symptoms of a
transfusion reaction and acting promptly and appropriately are
critical to reducing serious consequences to transfusion recipients.
- A list of common signs and symptoms of suspected adverse
reactions must be included in both nursing and transfusion service manuals.
- When any transfusion complication is
suspected, checking that the right blood went to right patient
should be one of the first steps after stopping the transfusion.
- Best practice for the immediate actions to
take whenever a transfusion complication is suspected include
- stopping the transfusion
- maintaining IV access
- checking identity
and compatibility ("right blood to right patient")
- notifying
the physician and transfusion service
- investigating
according to hospital policies and procedures.
- Standards and regulations exist for
investigating suspected transfusion complications, including
explicit requirements for hemolytic transfusion reactions, bacterial
sepsis, and transfusion-transmitted diseases.
Practical
Notes
- Signs and symptoms of transfusion complications with related
investigative actions must be present and easily accessible at nursing stations.
- Clinical staff who administer transfusion must be trained and
assessed in investigating suspected transfusion complications.
- When
investigating possible bacterial contamination:
- Treatment
for suspected bacterial contamination should be based on clinical
considerations, since delay in therapy may result in severe
morbidity or death.
-
Care should be taken when
collecting samples for culture from both
product and recipient to avoid external contamination of samples.
-
Gram
stain and cultures should be done on contents of the implicated
blood bags, not segments.
*
If you have comments on this section, please contact Pat:
.
TraQ self study questions
1.
Transfusion-related fever is
associated with which types of transfusion complications?

2. List
the immediate steps to take whenever a transfusion reaction is suspected.
3. Which
manuals must contain a list of the common signs and symptoms of
suspected adverse reactions?
MORE
DISCUSSION...
Part 3:
Scope of practice issues
Part 4.
Education
for interdisciplinary healthcare teams
FURTHER
READING
Literature
Hillyer CD, Josephson CD, Blajchman MA,
Vostal JG, Epstein JS, Goodman JL.
Bacterial contamination of blood components: risks, strategies, and
regulation: joint ASH and AABB educational session in transfusion
medicine. Hematology Am Soc Hematol Educ Program. 2003;575–89.
Kleinman S, Chan P, Robillard P.
Risks associated with transfusion of cellular blood components in
Canada. Transfus Med Rev. 2003 Apr;17(2):120–62.
Silva MA, Gregory KR, Carr-Greer MA, Holmberg JA, Kuehnert MJ,
Brecher ME; Task Force.
Summary of the AABB Interorganizational Task Force on Bacterial
Contamination of Platelets: Fall 2004 impact survey.Transfusion.
2006 Apr;46(4):636–41.
Other resources
Canadian Blood Services:
CSTM.
Standards for
Hospital Transfusion Services, v 2
UK:
2004 SHOT
Report

|